James Sullivan is a seasoned translational oncology leader specializing in clinical and companion diagnostic development, with a focus on innovative non-invasive diagnostic technologies. They hold a PhD in Cancer Biology from UT Southwestern Medical Center and have contributed to research at esteemed institutions such as Massachusetts General Hospital and Genentech. Having served as Head of External Technology Innovation Programs at Genentech, James has experience implementing advanced diagnostic strategies and has led significant projects in liquid biopsy and digital pathology. They aim to enhance healthcare effectiveness and affordability for cancer patients through early disease detection and accelerated drug development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices